"With this tremendous gift from The Anschutz Foundation, our goal is to fund the next Shingrix (vaccine) ... the next big, transformational innovations in health and medicine, particularly those that are just on the precipice of improving or saving lives," CU Anschutz Chancellor Donald Elliman told The Denver Gazette.